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Structurally simple synthetic molecules have proven useful for elucidating relation- 
ships between the structure and immunologic properties of antigens  (1, 2)  because it 
is possible to chemically modify such molecules to address specific questions. Although 
immunogens are generally considered to be large molecules--as opposed to haptens-- 
and the most potent clearly are, a number of noteworthy exceptions to this principle 
have been recorded. For example, L-tyrosine-p-azobenzene-p-arsonate (RAT), t with a 
molecular  weight  of only  -400  daltons,  induces  in  guinea  pigs  specific  delayed 
hypersensitivity, DNA synthesis  by lymphocytes from sensitized  animals,  and  func- 
tional carrier activity for anti-hapten responses (2).  However, the murine anti-hapten 
PFC response to the bifunctional antigen used in guinea pigs, N-2,4-dinitrophenyl-6- 
amino-caproyl-tyrosine-p-aminobenzine-p-arsonate (DNP-SAC-RAT), was extremely 
weak  (2).  Evidence  is  presented  here  that  the  response  to  this  antigen  in  mice  is 
exclusively of the IgM class in both primary and secondary responses. 
It is generally believed that IgM antibody responses are less T  dependent than IgG 
responses, and that carrier-specific helper T  cells are responsible for the switch from 
IgM to other Ig isotypes (3).  Indeed, it has been recently suggested that at least two 
types of carrier-specific helper cells synergize for optimal antibody responses, one of 
which is Ig-dependent (4). 
In view of these emerging concepts, a  possible basis for the weak, exclusively IgM 
anti-2,4-dinitrophenyl  (DNP)  plaque-forming cell  (PFC)  response in  mice to  DNP- 
SAC-RAT  could  be its  monovalency with  respect  to carrier epitopes, which  might 
limit interaction to a single helper T cell. This consideration prompted an investigation 
of  the  effect  of  adding  a  second  homologous  carrier  epitope  to  the  bifunctional 
conjugate, creating, in effect, a trifunctional antigen comprised of two identical carrier 
epitopes  and  a  single  haptenic  epitope.  The  murine  response  to  this  trifunctional 
antigen is the major theme of this report. 
* Aided by grant AI 05664 from the U. S. Public Health Service. 
~  Abbreviations used in  this paper: ABA, p-azobenzene-p-arsonate; Ac-PROI0-RAT, acetyl-(proline)10-tJ- 
tyrosine-p-)tzobenzene-p-arsonate;  BI-I [or DNP-SAC-RAT], N-2,4-dinitrophenyl-6-amino-caproyl-L-tyro- 
sine-p-azobenzene-p-arsonate;  BI-2 [or DNP-SAC-PROg-RAT],  N-2,4-dinitrophenyl-6-amino-caproyl-(pro- 
[ine)9-L-tyrosine-p-azobenzene-p-arsonate;  BI-3 [or DNP-SAC-PRO~0-RAT],  N-2,4-dinitrophenyl-6-amino- 
caproyl-(proline)10-L-tyrosine-p-azobenzene-p-arsonate;  CFA, complete Freund's adjuvant; DNP, 2,4-dini- 
trophenyl; DNP-SAC-PROg-TYR,  N-2,4-dinitrophenyl-6-amino-eaproyl-(proline)9-tyrosine;  GM, geomet- 
ric mean(s); HBSS, Hanks' balanced salt solution; KLH, keyhole limpet hemocyanin; MEM, minimum 
essential medium, PBS, phosphate-buffered saline; PFC, plaque-forming cell(s); PPS, PFC per spleen; 
RAT, L-tyrosine-p-azobenzene-p-arsonate;  SRBC, sheep erythrocytes; TNP, 2,4,6-trinitrophenyl(ated). 
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Materials and Methods 
Preparation of Ant,gens.  The antigens used in this study are listed in Table I. The synthesis of 
RAT, DNP-SAC-RAT, (or BI-I), and N-2,4-dinitrophenyl-6-amino-caproyl-(proline)9-L-tyro- 
sine-p-azobenzene-p-arsonate (DNP-SAC-PROg-RAT; or BI-2) have been previously reported 
(5, 6). 
The  antigens  BI-2  and  N-2,4-dinitrophenyl-6-amino-caproyl-L-tyrosine-p-azobenzene-p-ar- 
sonate-(proline)a0 (DNP-SAC-RAT-PROw; or BI-3) were prepared similarly to the trifunctional 
antigen, N-2•4-dinitr•pheny•-6-amin•-•apr•y•-L-tyr•sine-p-az•benzene•p-ars•nate•(pr••ine)9-L- 
tyrosine-p-azobenzene-p-arsonate (DNP-SAC-RAT-PRO9-RAT; or TRI).  TRI was prepared 
by the solid-phase synthesis method (7, 8) starting with N-tert-butoxyl-carbonyl-tyrosine (BOC- 
TYR)  (OBzClz)-resin and  using N-tert-butoxyl-carbonyl-(proline)3-OH (BOC-PRO3-OH)  for 
symmetrical anhydride fragment  coupling  (9).  A  detailed description of the  synthesis and 
purification of TRI will be published elsewhere (Manuscript in preparation.). 
After  purification,  TRI  was  characterized  by  spectrophotometric  analysis,  amino  acid 
analysis, and elementary analysis for arsenic. Spectra over the range of 300-540 nm showed the 
expected  qualitative and  quantitative  spectra  of DNP  and  mono-p-azobenzene arsenylate 
chromophores. Amino acid analysis yielded a ratio of proline:tyrosine of 5:1; the expected ratio 
is 4.5: 1. The elementary analysis was found to be 6.92%  for arsenic; the calculated value was 
7.4%. 
Animals and Immunization 
MICE.  Female A/J (H-2  a) mice 6-8 wk of age were purchased from The Jackson Laboratory, 
Bar Harbor, Maine. Mice used in these experiments were from 2 to 8 mo old. 
IMMUNIZATION,  The antigens were dissolved in phosphate-buffered saline (PBS) at 2 mg/ml 
and emulsified with an equal volume of complete Freund's adjuvant (CFA, Difco Laboratories, 
Detroit, Mich.). Typically, each A/J mouse received a  single injection of 100 #g of antigen 
intraperitoneally  in  0.1  ml  for  either  priming  or  boosting.  Mice  were  boosted  with  the 
TABLE  I 
The antigens 
MONOFUNCTIONAL:  RAT,  L-t  yrosine-p-az0btna,me-p-arsonat  e. 
H2N--CH--COOH 
I 
CH2 
~N~N  ~  AsOIH2 
OH 
BIFUNCTIONALS:  El- I, DNP-SAC-RAT, N-2,4-dinitrophenyl-6-amino-caproyl-L-tyro~ine-p-azobenzene.p.arsonate. 
BI-2, DNP-SAC-PRO,-RAT, N.2'4~dinitr~pheny~-6.amin~-capr~y~(pr~ine)9.L-tyr~sine.p-az~benzene~p~ars~nate. 
BI-3, DNP-SAC-RAT-PROIo, N-2,4-dinitrophenyl-6-amino-caproybL.tyrosine-p-azobenzene-p-arsonate. 
(proline)  lo. 
TRIFUNCTIONAL:  TRI, DNP-SAC-RAT-PRO~-RAT, N-2,4-dinitrophenyb6-amino-caproyl-g-tyrosine-p-azobenzene-p.arsonate- 
(proline)  r L-tyrosine-p-azobenzene-p-arsonate. 
HAPTEN DNP  SPACER  SAC  CARRIER RAT  SPACER  PROLINE9  CARRIER RAT 
(8 A)  (28 A) 
NO~  / 
O2N ~  NH--(CH2)s--'CO-- N  H-"CH--"CO ~  (N--HC---CO)s-- NH--'CH---COOH 
I  I  I  I 
CHz  HzG  CH2  CH2 
CH2 
HzO~As  ~  N~N  AsO3H 
OH  OH 
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appropriate antigen 30 d after priming. Control mice were  injected with 0.1  ml of emulsion 
prepared from equal volumes of PBS and CFA. 
PFC Assay.  Goat anti-mouse IgM (heavy chain specific) and rabbit anti-mouse IgG (heavy 
and  light  chain  specific)  antisera  were  purchased  from  N.  L.  Cappel  Laboratories,  Inc., 
Cochranville, Pa. Guinea pig complement, fetal calf serum (FCS), Hanks' balanced salt solution 
(HBSS), and minimum  essential medium (MEM) were purchased from Grand Island Biological 
Co., Grand Island, N. Y. 
Anti-DNP  PFC  were  assessed  using  2,4,6-trinitrophenylated  (TNP)-sheep  erythrocytes 
(SRBC)  as indicator cells(10)  in a  modification of the Jerne plaque assay  (11).  It  has been 
shown that equal numbers of anti-DNP PFC were detected in the same experiment using either 
DNP-SRBC or TNP-SRBC as indicator cells (12). Because  of the ease of preparation, TNP- 
SRBC were used in all the experiments and the results were expressed  as the number of anti- 
TNP PFC. 
On the day of PFC assay, single-spleen-cell  suspensions were prepared with HBSS at a final 
concentration  of 1 spleen/2 ml. 0.1 ml of TNP-SRBC (diluted 1:6) and 0.1 ml of the appropriate 
spleen cell suspension were added to 2 ml of 0.7% agar in MEM and the mixture was plated in 
9-cm plastic Petri dishes.  After incubating the dishes  at  37°C for  1 h,  2 ml of complement 
(guinea pig serum diluted appropriately in PBS)  was  added  to each dish.  The dishes  were 
incubated at  37°C  for  another hour,  the  complement was  poured  off, and  the  PFC  were 
counted. 
IgG PFC were detected by first  inhibiting IgM PFC with anti-IgM anti-serum, which was 
added to the cells before the plates were poured. Then, the IgG PFC were developed by adding 
anti-IgG antiserum with complement to the dishes after a  1-h incubation (13). 
Statistics.  Because the PFC responses to these antigens were relatively  weak, careful statistical 
analysis of the data was necessary.  Groups of five mice were used in each experiment except 
when indicated otherwise.  The PFC responses of individual mice were analyzed and recorded 
separately. It has been demonstrated that the logarithm of PFC responses  of individual mice 
follows  a  normal  distribution  (14). Therefore,  the  geometric  means  (GM;  which  are  the 
arithmetic means of the  log of the individual responses  of the groups)  were  calculated and 
expressed  in both Figures and Tables. SE  (SD  of the means of samples of n variates) were 
calculated using the equation SE -- (n)l/2.(n/n-1)l/2.s; where s is the SD of the samp!e (15). 
The upper limit of the GM is log  -1 (log GM +  SE)  =  log  -1 (log GM) ×  log  -1 (SE) -- GM × 
log  -1 SE.  By the same method, the lower limit of the GM is GM +  log -1 SE. Therefore, the 
form GM ×/+ log  -I SE is used in all Figures and Tables to express the GM and its upper and 
lower limits. 
The significance of experimental results were determined by the parametric Student's t test. 
In addition, the nonparametric Mann-Whitney U  test  (i.e., Wilcoxon's test  for the unpaired 
cases) was also performed for further confirmation. A two-tailed table was used with P <  0.05 
considered significant and P <  0.01 considered highly significant. 
Results 
Primary Antibody Responses to Bl-I  (DNP-SAC-RAT) and TRI.  Immunization of A/ 
J  mice with either BI-1  or TRI  (100 #g in CFA)  led to significant direct anti-TNP 
PFC responses; 4,074 PFC/spleen by BI-1  vs.  2,115 PFC/spleen by CFA control on 
day 13, and 12,477 PFC/spleen by TRI vs. 6,262 PFC/spleen by CFA control on day 
7 (Figs.  1 and 2). The  100-/.tg dose used for both antigens was based on a preliminary 
dose-kinetics study which demonstrated that this dose was optimal among the various 
doses tested (e.g.,  1,  10,  100, and  1,000 #g) when PFC responses were assayed on day 
7 and day  10 after priming. The high response by the CFA control group in Fig.  1 
was an exception to the average responses of CFA controls in all experiments (2,000- 
3,000 PFC/spleen). Both responses were extremely weak and consisted exclusively of 
IgM  PFC.  Their  detection  required  the  plaquing of large  numbers of cells  (1/20 
spleen equivalent). The significance of both responses was shown by the two-tailed 1673 
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FIG.  1.  The primary direct anti-TNP PFC response to BI-1. Groups of five mice each (in this and 
all subsequent figures) were immunized intraperitoneally with 100/Lg of BI- 1 in CFA, or with PBS 
in CFA. The GM and their upper and lower limits are expressed in this and all subsequent figures. 
Solid circles represent BI-l-immunized mice and open circles represent CFA-injected mice.  PPS, 
PFC per spleen. Responses earlier than  11 d were monitored in one experiment, which showed no 
significant response to BI-I (e.g., 2,481 PPS by BI-1 vs.  1,894 PPS by CFA control on day 5; 2,795 
PPS by BI-1 vs. 2,042  PPS by CFA control on day 7; data not shown.) 
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FIe.  2.  The primary direct anti-TNP PFC response to TRI. Solid circles represent TRI-immunized 
mice and open circles represent CFA-injected mice. 
Student's  t  test and  the two tailed nonparametric  Mann-Whitney  U  test  (P <  0.01  at 
some  time  points  and  P  <  0.05  at  others).  Because  these  antigens  are  very  small 
molecules  (BI-1,688  mol wt;  TRI,  1,954  mol wt),  it was considered  that  the kinetics 
of  the  antibody  responses  might  be  different  from  those  to  classical  proteins  or 
haptenated  protein  antigens.  Accordingly,  the responses  to  BI-1  were  followed  daily 
from day 5  to day 29, and  responses to TRI  were followed daily from day 5  to day 27 
after immunization  in two separate experiments  (partial results shown  in Figs.  1 and 1674  ANTIGEN  STRUCTURE  AND  ISOTYPE  SWITCHING 
2).  No significant anti-TNP IgG PFC responses were observed throughout  the entire 
period. For anti-TNP IgM PFC, the response to BI-1 reached peak levels between day 
9  and  13,  and  the  response  to  TRI  peaked  between  day  7  and  9.  In  subsequent 
experiments, primary responses were followed from day 7 to  14 after immunization. 
There was no qualitative difference found between the primary responses to BI-1 
and  TRI  in  that  only direct  PFC  were observed.  However, there  was  a  small  but 
significant  quantitative  difference.  The  peak responses  to  the  two  antigens  in  four 
separate experiments were as follows (plaques per spleen expressed as the GM of five 
individual mice): 4,899 (day 11) and 4,911  (day 13) to BI-I; 12,477  (day 7) and 8,596 
(day 7, four mice only) to TRI. To confirm these small differences in the kinetics and 
intensity  of the  IgM  PFC  responses to  the  two antigens,  they were compared in  a 
group of mice immunized simultaneously in two experiments. The results confirmed 
that TRI did, indeed, induce an earlier and about twofold higher response than BI-1 
(10,125  ×/+  1.27  PFC/spleen  on day 8  to TRI vs.  6,322  ×/+  1.16  PFC/spleen  on 
day  11  to BI- 1).  Pooling the results of six separate experiments, the GM of PFC per 
spleen on peak days were 5,016 ×/+  1.10 for BI-1 and  10,002  ×/+  1.10 for TRI. The 
difference was highly significant (P <  0.01)  by the two tests employed. 
Secondary Antibody Responses to BI-1 and TRI.  A/J mice were primed and boosted  1 
mo later with  100/~g of BI-1 or TRI in CFA, and their anti-TNP PFC of both IgM 
and  IgG classes were followed from day 4  to day 9  or  10 after secondary injection. 
Although  only quantitative  differences in  the  primary anti-TNP  responses  to  BI-1 
and  TRI  were  found,  both  quantitative  and  qualitative  differences  between  the 
secondary  antioTNP  PFC  responses  to  the  two  antigens  were  observed  (Fig.  3). 
Although no IgG PFC appeared in the secondary response to BI-1, both IgM and IgG 
PFC  appeared  in  the  secondary  response  to  TRI.  The  anti-TNP  IgG PFC  of the 
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secondary  response  to  TRI  reached  1,615  ×/+  1.72  PFC/spleen  on  day  5  after 
boosting,  compared  with  the  background  responses  to  BI-1  of-50  PFC/spleen 
followed from day 2 to d  11 after boosting with BI- 1. 
Consistent and significant anti-azobenzene-p-arsonate (ABA)  PFC responses have 
not  been observed in A/J  mice immunized with  BI-1  or TRI, whereas substantial 
anti-ABA PFC  (-50,000 PFC/spleen)  have been detected in mice immunized with 
500 ~g ABA-keyhole limpet hemocyanin (KLH) in CFA  (data not shown). Because 
the existence of antibody-dependent helper T cells has been suggested (8), ABA-KLH- 
primed mice were included in  the initial experiment to increase the probability of 
eliciting putative antibody-dependent help, and, hence, to assess  its possible role in 
other responses. The results (Fig. 3) showed that both anti-TNP IgM and IgG PFC 
were detected in mice boosted with TRI, regardless of whether they were primed with 
TRI or ABA-KLH. The anti-TNP IgM response peaked at a level of -10,000 PFC/ 
spleen, which was about  the same as the primary anti-TRI response  (Fig.  2). The 
anti-TNP IgG PFC  reached  1,615  PFC/spleen  on day 5  in TRI-primed mice, and 
500 PFC per spleen on day 6 in ABA-KLH-primed mice. However, there was no anti- 
TNP IgG PFC response in mice boosted with BI-1 after priming with BI-1 or ABA- 
KLH (data not shown), in spite of there being about the same number of IgM PFC 
as in mice boosted with TRI. The IgG PFC responses were highly significant  (P < 
0.01  by both parametric and nonparametric tests) in TRI-primed mice on days 5,  7, 
and 9, and in ABA-KLH-primed mice on day 6;  and were significant ~(P <  0.05 by 
both tests) in TRI-primed mice on days 6 and 8 (Fig. 3). The peak IgG PFC responses 
were -80 times background in TRI primed mice and 25 times background in ABA- 
KLH-primed mice. 
It should be pointed out that mice primed and boosted with BI-1 made a  higher 
secondary than  primary anti-TNP  IgM  PFC  response.  This suggested  a  degree of 
immunological memory differing from that of mice primed and boosted with TRI, in 
which the secondary anti-TNP IgM PFC response was not higher, but an IgG PFC 
response emerged. 
To further investigate the critical requirements for inducing IgG PFC responses, 
mice were primed with TRI and boosted with  BI-1  or were primed with BI-1  and 
boosted with TRI. Assays from days 3 to  12 revealed that  anti-TNP IgG PFC only 
appeared in mice boosted with TRI, not in those primed with TRI and boosted with 
BI-1  (partial results shown in Fig. 4). The IgG PFC responses in TRI-boosted mice 
were highly significant (P <  0.01 by both tests) from day 6-11 after boosting, and the 
peak response (427 PFC/spleen)  was -20-fold higher than background responses in 
BI- 1-boosted mice. 
The induction of anti-TNP IgG PFC in mice primed with BI-1 and boosted with 
TRI  (Fig.  4)  suggested  that  it  is  unlikely  that  BI-I  induced  Ig  class-specific and 
antigen-specific suppressor T  cells that were responsible for the absence of anti-TNP 
IgG PFC responses after secondary challenge with BI-1. Moreover, the induction of 
IgG PFC in mice primed with ABA-KLH and boosted with TRI  (Fig. 3)  indicated 
that DNP-primed B cells were not necessary for the induction of anti-TNP IgG PFC 
responses. 
Minimum Requirements for  Induction of IgG Antibody Responses by  TRI.  To  further 
determine the minimum requirements for inducing IgG PFC in this relatively simple 
and well-characterized system, mice were primed with RAT (409 mol wt), a  mono- 1676  ANTIGEN  STRUCTURE AND  ISOTYPE  SWITCHING 
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functional  T  cell  immunogen.  These  mice  were  then  boosted  with  TRI  and  their 
responses were followed from day 5 to  10 in two separate experiments (partial results 
of one experiment shown  in  Fig.  5).  Significant anti-TNP  IgG PFC responses  were 
given by  RAT-primed mice on  days 6  and  7  (P <  0.01),  whereas no anti-TNP IgG 
PFC responses were detected in CFA-injected and TRI-boosted mice, which mounted 
about the same anti-TNP IgM PFC responses as those of RAT-primed mice. However, 
the  IgG PFC  responses were much weaker than  those of TRI-primed mice (used  as p.  CHEN, D. E.  NITECKI, G. K. LEWIS, AND J.  w. GOODMAN  1677 
the positive control), 278 X/-  1.47 PFC/spleen by RAT-primed mice vs.  1,719 ×/+ 
2.1 PFC/spleen by TRI-primed mice (Fig. 5). The differences were highly significant 
on day 8 (P< 0.01) and significant on day 10 (P< 0.05 by the Student's t test only). 
In addition, no significant anti-TNP IgG PFC were detected in mice primed with 
RAT, boosted with BI-1, and followed from day 5 to 7 (one experiment) or day 5 to 
9 (one experiment) (data not shown). 
These results (Figs. 3-5) indicate that the minimum requirements for IgG antibody 
induction are carrier priming with a mono-epitope carrier (e.g.,  RAT), and boosting 
with  an  antigen  that  has  a  minimum  of two carrier determinants.  Moreover, the 
weaker anti-TNP IgG PFC responses in RAT-primed mice than in mice primed with 
BI-1  or TRI  suggested  that  DNP-priming can  significantly enhance the anti-TNP 
IgG PFC response, although it was not a necessity. 
Role of the Spacer in IgG Induction.  Although BI-1  (DNP-SAC-RAT)  induced only 
IgM anti-TNP PFC even after boosting, TRI induced both IgM and IgG PFC after 
priming  and  boosting  (Fig.  3).  Moreover,  anti-TNP  IgG  PFC  appeared  in  mice 
primed with  RAT or BI-1  and  boosted with TRI  (Figs.  4  and  5).  Thus,  it was of 
interest to determine the critical features in the structures of BI-1 and TRI responsible 
for the induction of IgG PFC responses. 
The  major structural  differences between  TRI  and  BI-1  include:  (a)  two  RAT 
carrier epitopes in TRI vs. one RAT carrier epitope in BI- 1;  (b) a  sequence of nine 
proline residues as spacer in TRI vs. no proline residues in BI-1; and (c) a distance of 
~36  A  between the  DNP  haptenic epitope and  one carrier epitope in  TRI  (SAC- 
RAT-PROg) vs. the maximum span of 8 A of the SAC spacer in BI-1. To define the 
critical factor(s)  that  activate(s)  IgG PFC,  additional  model antigens with selected 
properties were prepared, as follows: (a) DNP-SAC-PRO9-RAT (BI-2), with a spacer 
consisting of nine proline residues plus a  SAC group, thereby simulating the spacer 
between  DNP  and  RAT  in  TRI;  (b)  DNP-SAC-RAT-PRO10  (BI-3),  in  which  a 
proline  residue  was  substituted  for  the  second  RAT  moiety  of TRI.  These  two 
compounds provide bifunctional antigens with spacers that are found in TRI. They 
were used  to assess  whether the IgG response induced by TRI  was  a  result  of the 
second RAT epitope or to the arrangement of the spacer groups. 
The earlier results showed that priming with TRI induced the strongest IgG PFC 
responses, and that the responses appeared between day .5 and 9 after boosting (Figs. 
3-5). Therefore, mice were primed with TRI, boosted with appropriate antigens, and 
followed from day 5 to 9 to detect anti-TNP IgG PFC responses induced by BI-2 and 
BI-3 (partial results shown in Fig. 6). It can be seen that BI-2 induced anti-TNP IgG 
PFC responses in TRI-primed mice, whereas BI-3 did not. The anti-TNP IgG PFC 
response by BI-2-boosted mice reached 2,462  ×/+  2.20  PFC/spleen  on day 5  and 
1,915 ×/+  1.33 PFC/spleen on day 8, in contrast to the background response by BI- 
3-boosted  mice  of only  ~70  PFC/spleen  throughout  the  period.  However,  BI-3 
induced significant anti-TNP IgM PFC: 6,778 ×/+  1.10 PFC/spleen vs. 2,910 ×/+ 
1.22  PFC/spleen  in  CFA-injected  mice  (data  not  shown;  P  <  0.01  by both  tests). 
Moreover, BI-2  and  BI-3  induced  about  the  same  anti-TNP  IgM  PFC  responses: 
6,778 ×/+  1.10 PFC/spleen by BI-3 vs. 3,917 ×/+  1.06 PFC/spleen by BI-2 in one 
experiment  (Fig.  6);  and  4,244  ×/+  1.09  PFC/spleen  by BI-3  vs.  4,948  ×/+  1.09 
PFC/spleen by BI-2 in another experiment (data not shown). 
Because mice primed with TRI gave about equivalent anti-TNP IgG PFC responses 1678  ANTIGEN STRUCTURE AND ISOTYPE SWITCHING 
1QO00 
W 1,ooo 
G 
Z 
I- 
! 
C  100 
10 
BI-2  BI-3 
/ 
iii 
I  I  I  I  I  I  I  I 
5678  5678 
OAYS 
Flo. 6.  Anti-TNP  PFC  responses of mice primed with TRI and boosted with  the  indicated 
antigens. Solid lines  represent BI-2 boosted mice; dashed lines represent BI-3 boosted mice; squares 
represent IgM PFC responses; circles represent IgG PFC responses. 
TABLE II 
Secondary Anti- TNP IgG PFC Responses to  TRI and BI-2 in Mice Primed with RA T or 
Ac-PROto-RA T* 
Days:l: 
RAT-primed and TRI-  RAT-primed and BI-2-  Ac-PROto-RAT-primed  and 
boosted  boosted  BI-2-boosted 
Experiment 1  Experiment 2  Experiment 3  Experiment  4  Experiment 3  Experiment 5 
5  l0  252  14  14  27  55 
6  252  80  37  20  74  25 
7  225  61  42  19  225  35 
8  10  28  ND§  34  109  216 
* Groups of five mice each were primed with 100 gg of RAT or Ac-PRO]0-RAT  in CFA and boosted with 
100 p.g of TRI or BI-2 in CFA 1 mo later. The GM of IgG PFC/spleen are expressed. 
Days after boosting. 
§ ND, not done. 
when boosted with BI-2 or TRI (Figs. 3 and 6; and additional data not shown), it was 
of interest to determine if priming with TRI was essential for the IgG response to BI- 
2.  As observed earlier, priming with RAT and boosting with TRI gave rise to anti- 
TNP IgG PFC (Fig. 5). Accordingly, mice were primed with RAT and boosted with 
BI-2 and BI-3. In contrast to boosting with TRI, neither of the bifunctional antigens 
induced anti-TNP IgG PFC responses in mice primed with RAT. The data for BI-2 
are shown in Table II. Thus, BI-2 and TRI are not equivalent in their capacity to 
induce IgG antibody responses. 
Our interpretation of these findings is that priming with TRI could induce anti- 
polyproline antibody, which might cross-link BI-2 molecules into aggregates consisting 
of  at  least  two  BI-2  molecules.  These  poly-BI-2  molecules  could  then  meet  the 
requirement of having at  least  two carrier epitopes per  molecule for  inducing IgG 
antibody responses.  Alternatively, polyproline or  polyproline-anti-polyproline  com- P.  CHEN,  D.  E.  NITECKI, G.  K.  LEWIS,  AND J.  w.  GOODMAN  1679 
plexes  might  function  as  a  second  carrier in  addition  to  the  RAT  carrier,  which 
implies that different carrier-specific helper T  cells which recognize different carriers 
might synergize in activating the IgG antibody response. 
To assess  the possible formation of anti-polyproline antibodies and their role(s) in 
inducing anti-TNP IgG PFC, another antigen, acetyl-(proline)10-L-tyrosine-p-amino- 
benzene-p-arsonate (Ac-PRO10-RAT), was prepared (16). Mice were primed with Ac- 
PRO10-RAT and boosted with BI-2. It can be seen  (Table II)  that significant anti- 
TNP IgG PFC responses were detected (P <  0.05 compared with mice primed with 
RAT  or  CFA,  and  boosted  with  BI-2;  by  the  two-tailed  Student's  t  test  only). 
Moreover,  this  IgG  response  was  equivalent  to  the  anti-TNP  IgG  PFC  response 
induced by RAT-priming and TRI-boosting (Table II). 
The possible induction of anti-polyproline antibodies and their effect  (s) were further 
assessed by serum transfer experiments. Mice were primed with Ac-PRO10-RAT in 
CFA and  their putative anti-polyproline anti-sera were collected  1 mo later.  Mice 
that had been primed 1 mo earlier with RAT in CFA were injected intraperitoneally 
with  various  quantities  of the  putative  antipolyproline  antisera  and  immunized 
simultaneously with  BI-2 in CFA. The results from one experiment, followed from 
day 5  to 8  after challenge, were equivocal. As described earlier, the anti-TNP IgG 
PFC  responses  induced  by either  RAT-priming  with  TRI-boosting or Ac-PRO10- 
RAT-priming with BI-2-boosting (Table II) were extremely weak and on the border- 
line of significance. This suggested that  a  large number of mice had  to be used, a 
minimum of 10/day (including 5 mice as controls) for a  minimum period of 4 d, to 
detect responses of this magnitude. The cost of this already risky series of experiments 
was further increased by the large number of mice used to prepare and titrate the 
putative antipolyproline antisera. Together, these factors made it unrealistic to further 
pursue the possible role of anti-polyproline antibodies in the IgG responses by serum 
transfer experiments. 
To test the possible carrier function of polyproline in BI-2, another new antigen, N- 
2,4-dinitrophenyl-6-amino-caproyl- (proline)9-  L-tyrosine  (DNP-SAC-PRO9-TYR), 
was used. This compound is an intermediate in the synthesis of BI-2, used for the last 
step of diazonium coupling.  DNP-SAC-PROs-TYR did not induce significant anti- 
TNP antibody responses of either class, either in  primary responses  (followed from 
day 6  to  11  after priming)  or secondary responses  (followed from day 5  to 9  after 
boosting)  in  mice primed with TRI  in CFA  1 mo earlier  (data not  shown).  These 
results suggest that the polyproline spacer in BI-2 does not function as a carrier. The 
cumulative findings favor, but do not prove, the interpretation that IgG induction by 
BI-2 is mediated by anti-prolyl antibody. The failure of such antibody to mediate 
IgG  induction  by  BI-3  is  unclear,  but  may  be  related  to  spatial  features  of the 
molecule that prevent aggregation. 
Discussion 
The central conclusion to be drawn from these experiments is that the minimum 
requirement for IgG antibody formation in mice is priming with a  monofunctional 
carrier and  boosting with a  trifunctional antigen consisting of two carrier epitopes 
and a single haptenic epitope. The anti-hapten IgG PFC responses resulting from this 
regimen were extremely weak, requiring the plaquing of large numbers of spleen cells 
for their unequivocal detection. Parenthetically, it should be noted that priming with 1680  ANTIGEN STRUCTURE AND ISOTYPE SWITCHING 
more complex antigens bearing ABA epitopes (BI-t and ABA-KLH) sufficed as well 
or better for IgG responses, the essential factor being boosting with a molecule bearing 
at least two carrier eiptopes. This was exemplified by the inability of BI- 1 to induce 
IgG responses in mice primed with TRI, whereas the converse engendered IgG PFC. 
Primary responses to bi- and trifunctional antigens were exclusively IgM;  IgG PFC 
were observed only in secondary responses. We interpret this as a requirement for the 
expansion of helper 1- cells, although ABA-specific B cells are also expanded by RAT 
(2) and may play a role in the development of IgG anti-hapten responses, as discussed 
below. It is apparent that expansion of hapten-specific B cells is not required for IgG 
responses, because RAT sufficed as a priming agent for anti-DNP IgG PFC. 
An exception to the general requirement for two carrier epitopes for IgG responses 
was  apparently  made  by the  IgG response in  mice boosted with  the  bifunctional 
compound BI-2. This compound, as well as BI-3, was synthesized to assess the role, if 
any, of the polyproline spacer in TRI in isotype switching. The combined evidence 
from a number of experiments supports the interpretation that anti-prolyl antibodies 
were responsible for the effect, perhaps by cross-linking BI-2 into aggregates which 
would  then,  in  effect,  possess  the  plurality  of carrier  epitopes  required  for  IgG 
production.  For one thing, anti-prolyl antibodies were induced  in  guinea  pigs  im- 
munized with  the  bifunctional  antigen N-2,4-dinitrophenyl-(proline)10-L-tyrosine-p- 
aminobenzene-p-arsonate  (DNP-PROa0-RAT),  demonstrating  that  the  decaproline 
spacer also served as a  haptenic determinant  (17). The most telling observations in 
the present series of experiments involved the inability of BI-2 to induce IgG responses 
unless  proline-containing antigens were used  for priming.  Thus, BI-2 induced only 
IgM PFC in mice primed with RAT, but induced IgG as well as IgM PFC in animals 
primed with Ac-PRO10-RAT (Table II). Attempts were made to firmly establish the 
antibody mechanism  by transferring serum from mice immunized with Ac-PRO10- 
RAT into RAT-primed recipients, which were then challenged with BI-2. The results 
of the transfer experiments, as might be anticipated in view of the marginal response 
to these antigens, were inconclusive. Hence, the findings strongly suggested, but failed 
to conclusively prove, the antibody mechanism for isotype switching by BI-2. In any 
event, the ability of TRI coupled with the inability of BI-2 to induce IgG PFC  in 
mice primed with RAT is viewed as strong support for the conclusion that  at least 
two carrier epitopes are indeed required for isotope switching. 
A  remaining paradox was the failure of BI-3 to induce IgG PFC in mice primed 
with TRI (Fig. 6). The only apparent difference between BI-2 and BI-3 is the location 
of the polyproline spacer (Table I). If cross-linking by anti-prolyl antibody was indeed 
responsible for the IgG response to BI-2, it is difficult to visualize why BI-3 should be 
different  in  this  respect.  One  consideration  that  comes  to  mind  is  the  critical 
displacement  between  haptenic  and  carrier  epitopes  for  antibody  responses  (17). 
Because BI-2 and BI-3 induced about equal IgM PFC responses, the difference in IgG 
induction  implies that  spatial  requirements for IgM  and  IgG responses may differ. 
However, the experimental evidence is insufficient to resolve this question. 
Upon  considering plausible  mechanisms  by which  dual  carrier epitopes  dictate 
isotype switching by B cells, the obvious alternatives are:  (a) more efficient focusing 
of a singl  e type of T  cell help versus (b) the mediation of different synergizing forms 
of help.  The recent literature suggests that  a  single type of help, whether antigen- 
specific or  idiotype-specific, triggers only IgM  antibody  responses.  For one  thing, P.  CHEN, D. E.  NITECKI, G. K. LEWIS, AND J.  w.  GOODMAN  1681 
enriched antigen-specific helper T  (TH) cells from long-term cultures induced B cells 
from nude mice to secrete IgM, but not IgG, antibodies in vivo (18) and in vitro (19). 
For another, injection of serum antibodies induced direct PFC of the same specificity 
in normal mice, but not in nude mice, suggesting that Tn cells were involved (20). 
Moreover, monoclonal antibodies likewise induced direct PFC of identical specificity, 
whereas variant hybridoma products, in which the light chain came from the myeloma 
parent, were inactive, indicating that  the Tn cells involved were specific for self-Ig 
determinants. These findings, together with those supporting the existence of syner- 
gistic help (4), provide a  compelling argument  for the combined action of different 
forms of help in isotype switching. 
Accordingly, a model can be formulated in which, on a molecule of TRI bound by 
a DNP-specific B cell, one of the RAT epitopes focuses ABA-specific help, presumably 
in the form of a  soluble mediator, whereas the other RAT epitope binds anti-ABA 
antibody, which  in  turn serves a  determinant  to  focus the Ig-specific help.  In  this 
regard, the requirement for RAT-priming in the IgG response may be for the purpose 
of an early secondary anti-ABA antibody response rather than, or in addition to, the 
priming  of helper  T  cells,  because  expansion  of ABA-specific  B  cells  in  RAT- 
immunized mice has been demonstrated (2). 
Because a  B cell has many Ig receptors on its surface, it is likely that it may have 
many antigen molecules on its surface. In that case, a  molecule with a single carrier 
epitope, such as BI-1, should be able to focus both helper factors on the surface of an 
individual cell. Why, then, doesn't BI-1 induce IgG responses? One possibility is that 
a  given B  cell may capture very few antigen  molecules, particularly because these 
small molecules are likely to be cleared rapidly. Alternatively, the synergistic signals 
may  not  operate  through  distant  receptors  on  a  B  cell  surface,  but  may  require 
delivery in the immediate vicinity of the same hapten-binding receptor. At this point, 
one  can  only  speculate  about  the  detailed  mechanisms  of B  cell  activation  and 
immunoglobulin isotype switching. 
Summary 
L-Tyrosine-p-azobenzene-p-arsonate (RAT) is immunogenic and serves as a carrier 
for  anti-hapten  antibody  responses  in  guinea  pigs,  rats,  and  mice.  However, the 
murine anti-N-2,4-dinitrophenyl  (DNP)  plaque-forming cell  (PFC)  response to the 
bifunctional antigen 2,4-dinitrophenyl-6-amino-caproyl-L-tyrosine-p-azobenzene-p-ar- 
sonate (DNP-SAC-RAT;  or BI-1)  is extremely weak (2,000-4,000 PFC/spleen)  and 
exclusively IgM in both primary and secondary responses. The 6-amino-caproyl group 
serves as a spacer in this antigen between the DNP haptenic and RAT carrier epitopes. 
In  view of recent evidence indicating  that  different T  helper cells synergize for 
optimal  antibody  responses,  a  trifunctional  antigen,  N-2,4-dinitrophenyl-6-amino- 
capr•y•-L-tyr•sine-p-az•benze-p-ars•nate-(pr••ine)9-L-tyr•sine-p-az•benzene-p-ars•n- 
ate (DNP-SAC-RAT-PROg-RAT; or TRI), was prepared to investigate the effect of 
adding a second RAT epitope to BI-1. The nonaproline spacer between the two RAT 
epitopes in TRI is assumed to be a  rigid rod of-28  ,~. TRI induced about twice as 
many PFC as BI-I in primary responses of A/J mice, and induced both IgM and IgG 
PFC in secondary responses. Furthermore, TRI induced IgG PFC responses in mice 
primed  with  p-azobenzene-p-arsonate-keyhole limpet  hemocyanin,  BI-I,  or  RAT, 
whereas boosting with BI-1 failed to induce IgG PFC, even in mice primed with TRI. 1682  ANTIGEN STRUCTURE  AND ISOTYPE SWITCHING 
These findings indicate that the minimum antigen structural requirements for induc- 
ing IgG PFC in mice are two carrier epitopes and one haptenic epitope. In addition, 
priming with a mono-epitope carrier (RAT) is sufficient preparation for IgG responses 
to a trifunctional immunogen. 
Because TRI  differs from BI-1  by the  (proline)9 spacer as well  as the additional 
RAT epitope, two other compounds, N-2,4-dinitrophenyl-6-amino-caproyl-(proline)9- 
e-tyrosine-p-azobenzene-p-arsonate (DNP-SAC-PROg-RAT; or BI-2) and N-2,4-dini- 
t rophenyl-6-amino-caproyl-  (proline)a-e-tyrosine-p-azobenzene-arsonate  (DNP-SAC- 
RAT-PROa0; or BI-3), were prepared to evaluate the possible role of the spacer in the 
observed responses.  BI-2, but  not  BI-3, induced  IgG as well  as  IgM  PFC  in  TRI- 
primed  mice.  However, BI-2 failed  to  induce  IgG responses  in  RAT-primed  mice, 
indicating that TRI and BI-2 were not equivalent immunogens. Because anti-prolyl 
antibodies  had  been  found  in  guinea  pigs  immunized  with  N-2,4-dinitrophenyl- 
(proline) lo-L-tyrosine-p-azobenzene-p-arsonate (DNP-PRO10-RAT), it seemed possible 
that  priming with  TRI might  induce  anti-prolyl  antibodies,  which,  in  turn,  could 
cross-link BI-2 molecules into aggregates containing at least two carrier epitopes. To 
help resolve this question, mice were immunized with acetyl-(proline)10-L-tyrosine-p- 
azobenzene-p-arsonate  and  boosted  with  BI-2.  IgG  PFC  responses  were  detected, 
suggesting that anti-prolyl antibodies were indeed responsible, because priming with 
RAT and boosting with BI-2 did not induce IgG formation. 
Accordingly, the observations that IgG responses in RAT-primed mice were induced 
only by TRI and  not  by any of the bifunctional  antigens  indicate  that  two carrier 
epitopes  per  antigen  molecule  are  indeed  required  for  IgG  induction.  They  also 
provide indirect  evidence  for synergistic help  in  the  switching of immunoglobulin 
isotypes. 
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